These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29039496)

  • 1. GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Liu K; Li J; Wu X; Chen M; Luo F; Li J
    Int J Oncol; 2017 Dec; 51(6):1821-1830. PubMed ID: 29039496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells.
    Yu AS; Zhao L
    Tumour Biol; 2016 Apr; 37(4):4857-64. PubMed ID: 26526575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells.
    Luo F; Li J; Liu J; Liu K
    Cancer Gene Ther; 2022 Nov; 29(11):1707-1719. PubMed ID: 35750753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance.
    Luo F; Li J; Wu S; Wu X; Chen M; Zhong X; Liu K
    Oncotarget; 2016 Sep; 7(39):63937-63949. PubMed ID: 27613840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
    Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
    Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
    Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
    Ko KH; Holmes T; Palladinetti P; Song E; Nordon R; O'Brien TA; Dolnikov A
    Stem Cells; 2011 Jan; 29(1):108-18. PubMed ID: 20960517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway.
    Mao D; Qiao L; Lu H; Feng Y
    Neoplasma; 2016; 63(5):705-16. PubMed ID: 27468874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 12. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt/β-catenin signaling via negative modulation of GSK-3β.
    Jia Y; Huang X; Shi H; Wang M; Chen J; Zhang H; Hou D; Jing H; Du J; Han H; Zhang J
    Exp Cell Res; 2023 Aug; 429(2):113629. PubMed ID: 37187249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
    Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
    Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
    Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
    Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway.
    Wang G; Feng CC; Chu SJ; Zhang R; Lu YM; Zhu JS; Zhang J
    Int J Oncol; 2015 Nov; 47(5):1767-74. PubMed ID: 26398368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
    Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
    Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
    Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
    Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
    Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
    Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.